Merieux Equity Partners is an investment firm that specializes in healthcare and nutrition sectors.
Mérieux Développement is specialized in Growth and Venture capital transactions in the healthcare and nutrition sectors. We support companies with products or services offering true differentiation and capacity to create substantial value over the long term. Our investment team, based in Europe and North America, brings its expertise and international network to help entrepreneurs disrupt and grasp substantial market opportunities. Mérieux Développement is an affiliate of Institut Mérieux, which employs approximately 17,000 employees worldwide, with consolidated revenues exceeding 2.5 billion Euros in 2017.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 3, 2021
Amyl Therapeutics
|
Series A | €8.60M | Biotechnology | — |
Jan 19, 2016
Twist Bioscience
|
Series D | $61M | Biotechnology | — |